Caribou Biosciences (CRBU) Change in Receivables (2020 - 2025)
Caribou Biosciences has reported Change in Receivables over the past 6 years, most recently at -$173000.0 for Q4 2025.
- Quarterly Change in Receivables rose 64.98% to -$173000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$196000.0 through Dec 2025, up 57.21% year-over-year, with the annual reading at -$196000.0 for FY2025, 57.21% up from the prior year.
- Change in Receivables was -$173000.0 for Q4 2025 at Caribou Biosciences, down from -$152000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $2.8 million in Q2 2021 and troughed at -$3.5 million in Q3 2021.
- The 5-year median for Change in Receivables is -$175000.0 (2025), against an average of -$148650.0.
- Year-over-year, Change in Receivables plummeted 1012.11% in 2021 and then surged 7550.0% in 2025.
- A 5-year view of Change in Receivables shows it stood at $575000.0 in 2021, then plummeted by 184.35% to -$485000.0 in 2022, then soared by 62.06% to -$184000.0 in 2023, then crashed by 168.48% to -$494000.0 in 2024, then soared by 64.98% to -$173000.0 in 2025.
- Per Business Quant, the three most recent readings for CRBU's Change in Receivables are -$173000.0 (Q4 2025), -$152000.0 (Q3 2025), and $306000.0 (Q2 2025).